Abstract:Our finding provided new knowledge for understanding how androgen determines the dual roles of AR on prostate cancer metastasis. We made new discovery that androgen promotes metastasis of AR‐positive PCa via regulation of hsa‐miR‐203a, hsa‐miR‐210‐3p, hsa‐miR‐5001‐5p, and YAP. The finding of the pathway AR/androgen/miRNAs/YAP offered an opportunity for developing novel drugs to delay or to suppress the PCa metastasis. Background Prostate cancer (PCa) patients with elevated level of androgen receptor (AR) correlate with higher metastatic incidence. Protein expression of AR and its target gene prostate‐specific antigen (PSA) are elevated in metastatic prostate tumors as compared to organ‐confined tumors. Androgen treatment or elevation of AR promotes metastasis of PCa in cell culture and murine model. However, under androgen depleted condition, AR suppressed cell mobility and invasiveness of PCa cells. Androgen deprivation therapy in PCa patients is associated with higher risk of cancer metastasis. We therefore investigated the dual roles of AR and miRNAs on PCa metastasis. Methods The PC‐3AR (PC‐3 cells re‐expressing AR) and LNCaP cells were used as PCa cell model. Transwell migration and invasion assay, wound‐healing assay, zebrafish xenotransplantation assay, and zebrafish vascular exit assay were used to investigate the role of AR and androgen on PCa metastasis. Micro‐Western Array, co‐immunoprecipitation and Immunofluorescence were applied to dissect the molecular mechanism lying underneath. The miRNA array, miRNA inhibitors or plasmid, and chromatin immunoprecipitation assay were used to study the role of miRNAs on PCa metastasis. Results In the absence of androgen, AR repressed the migration and invasion of PCa cells. When androgen was present, AR stimulated the migration and invasion of PCa cells both in vitro and in zebrafish xenotransplantation model. Androgen increased phospho‐AR Ser81 and yes‐associated protein 1 (YAP), decreased phospho‐YAP Ser217, and altered epithelial‐mesenchymal transition (EMT) proteins in PCa cells. Co‐IP assay demonstrated that androgen augmented the interaction between YAP and AR in nucleus. Knockdown of YAP or treatment with YAP inhibitor abolished the androgen‐induced migration and invasion of PCa cells, while overexpression of YAP showed opposite effects. The miRNA array revealed that androgen decreased hsa‐miR‐5001‐5p but increased hsa‐miR‐203a and hsa‐miR‐210‐3p in PC‐3AR cells but not PC‐3 cells. Treatment with inhibitors targeting hsa‐miR‐203a/hsa‐miR‐210‐3p, or overexpression of hsa‐miR‐5001‐5p decreased YAP expression as well as suppressed the androgen‐induced migration and invasion of PCa cells. Chromatin immunoprecipitation (ChIP) assay demonstrated that AR binds with promoter region of has‐miR‐210‐3p in the presence of androgen. Conclusions Our observations indicated that miRNAs 203a/210‐3p/5001‐5p regulate the androgen/AR/YAP‐induced PCa metastasis.

Androgen Receptor Suppresses Prostate Cancer Metastasis but Promotes Bladder Cancer Metastasis Via Differentially Altering Mirna525-5P/slpi-mediated Vasculogenic Mimicry Formation

Androgen receptor-regulated miRNA-193a-3p targets AJUBA to promote prostate cancer cell migration.

Identification of Novel AR-Targeted MicroRNAs Mediating Androgen Signalling Through Critical Pathways to Regulate Cell Viability in Prostate Cancer

The miRNAs 203a/210‐3p/5001‐5p regulate the androgen/androgen receptor/YAP‐induced migration in prostate cancer cells

Anti-androgen Therapy Induces Transcriptomic Reprogramming in Metastatic Castration-Resistant Prostate Cancer in a Murine Model.

Androgen Receptor (AR) Promotes Male Bladder Cancer Cell Proliferation and Migration Via Regulating CD24 and VEGF.

Targeting Androgen Receptor (AR) with Antiandrogen Enzalutamide Increases Prostate Cancer Cell Invasion Yet Decreases Bladder Cancer Cell Invasion Via Differentially Altering the AR/circRNA-ARC1/miR-125b-2-3p or Mir-4736/Pparγ/mmp-9 Signals

The androgen receptor plays a suppressive role in epithelial- mesenchymal transition of human prostate cancer stem progenitor cells

Androgen Receptor-Mediated Downregulation of Microrna-221 and -222 in Castration-Resistant Prostate Cancer

A transcriptional target of androgen receptor, miR-421 regulates proliferation and metabolism of prostate cancer cells.

Regulation and Methylation of Tumor Suppressor Mir-124 by Androgen Receptor in Prostate Cancer Cells.

Targeting the Androgen Receptor with Sirna Promotes Prostate Cancer Metastasis Through Enhanced Macrophage Recruitment Via CCL2/CCR2-induced STAT3 Activation

Androgen-induced Mir-135A Acts As a Tumor Suppressor Through Downregulating RBAK and MMP11, and Mediates Resistance to Androgen Deprivation Therapy.

Abstract 470: AR-induced miRNA124-3p.2 suppresses the metastasis-promoting factor CCL2

Androgen Receptor Transcriptionally Inhibits Programmed Death Ligand-1 Expression and Influences Immune Escape in Bladder Cancer

Inhibition of Androgen Receptor Signaling Promotes Prostate Cancer Cell Migration via Upregulation of Annexin A1 Expression

Androgen receptor modulates metastatic routes of VHL wild-type clear cell renal cell carcinoma in an oxygen-dependent manner

Activated Androgen Receptor Promotes Bladder Cancer Metastasis Via Slug Mediated Epithelial-Mesenchymal Transition

Infiltrating Mast Cells Enhance Prostate Cancer Invasion Via Altering LncRNA-HOTAIR/PRC2-androgen Receptor (AR)-MMP9 Signals and Increased Stem/progenitor Cell Population

MicroRNA-185 Suppresses Proliferation, Invasion, Migration, and Tumorigenicity of Human Prostate Cancer Cells Through Targeting Androgen Receptor

Androgen receptor regulated microRNA miR-182-5p promotes prostate cancer progression by targeting the ARRDC3/ITGB4 pathway.